366016-86-6

Basic information

• Product Name: 1-(benzyloxy)-3-(3-iodopropyl)benzene
• Synonyms: 1-(benzyloxy)-3-(3-iodopropyl)benzene
• CAS NO: 366016-86-6
• Molecular Weight: 352.215
• Mol File: 366016-86-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-(benzyloxy)-3-(3-iodopropyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(benzyloxy)-3-(3-iodopropyl)benzene(366016-86-6)
• EPA Substance Registry System: 1-(benzyloxy)-3-(3-iodopropyl)benzene(366016-86-6)

Safety Data

• Hazardous Substances Data: 366016-86-6(Hazardous Substances Data)

Upstream product

• 57668-35-6 3-[3-(Benzyloxy)phenyl]-1-propanol 
• 100-39-0 benzyl bromide 
• 1424-74-4 3-(3-hydroxyphenyl)propanol 
• 149505-02-2 1-benzyloxy-3-[3-(methanesulphonyloxy)propyl]-benzene 

Downstream Products

• 366016-97-9 3-{1-[3-(3-benzyloxyphenyl)propyl]-1H-imidazol-2-yl}-1,2-propanediol 
• 366016-94-6 2-(1-{3-[3-(Benzyloxy)phenyl]propyl}-1H-imidazol-2-yl)-1-ethanol 
• 1034016-67-5 4-(3-{3-[5-(diphenylmethyl)-2-oxopyridin-1(2H)-yl]propyl}phenoxy)butanoic acid 
• 1034022-18-8 5-(diphenylmethyl)-1-[3-(3-hydroxyphenyl)propyl]pyridin-2(1H)-one 
• 1034020-42-2 ethyl 2-(3-{3-[5-(diphenylmethyl)-2-oxopyridin-1(2H)-yl]propyl}phenoxy)propanoate 
• 1034019-25-4 ethyl 4-(3-{3-[5-(diphenylmethyl)-2-oxopyridin-1(2H)-yl]propyl}phenoxy)butanoate 
• 1034017-48-5 2-(3-{3-[5-(diphenylmethyl)-2-oxopyridin-1(2H)-yl]propyl}phenoxy)propanoic acid 
• 1356397-82-4 2-(3-{3-[5-(diphenylmethyl)-2-oxopyridin-1(2H)-yl]propyl}phenoxy)butanoic acid 
• 1034019-51-6 1-{3-[3-(benzyloxy)phenyl]propyl}-5-(diphenyl-methyl)pyridin-2(1H)-one 

Relevant articles and documents

Discovery of novel and potent CRTH2 antagonists

High throughput screening of our chemical library for CRTH2 antagonists provided a lead compound 1a. Initial optimization of the lead led to the discovery of a novel, potent and orally bioavailable CRTH2 antagonist 17.

MEDICINAL COMPOSITIONS IMPROVED IN SOLUBLITY IN WATER

Solid dispersions are provided comprising an HER2 inhibitor which is hardly or not soluble in water and a hydrophilic polymer. These solid dispersions have been improved in the solubility of the HER2 inhibitor, oral absorption and bioavailability in blood

Heterocyclic compounds their production and use

A compound represented by the formula: wherein m is 1 or 2, R1 is a halogen or an optionally halogenated C1-2 alkyl; one of R2 and R3 is a hydrogen atom and the other is a group represented by the formula: wherein n is 3 or 4; R4 is a C1-4 alkyl group substituted by 1 or 2 hydroxy groups, or a salt thereof shows tyrosine kinase-inhibiting activity.